시장보고서
상품코드
1296067

세계의 차세대 시퀀싱(NGS) 시장(2023-2027년)

Global Next Generation Sequencing Market 2023-2027

발행일: | 리서치사: TechNavio | 페이지 정보: 영문 171 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

차세대 시퀀싱(NGS) 시장은 2022-2027년간 34억 976만 달러 확대되고, 예측 기간 동안 12.45%의 CAGR을 나타낼 것으로 예상됩니다.

본 보고서에서는 차세대 시퀀싱(NGS) 시장의 전반적인 분석, 시장 규모와 예측, 동향, 시장 성장 촉진요인 및 저해요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등을 정리하여 전해드립니다.

현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 NGS 방법의 사용 증가, 유전성 질환의 조기 진단에 대한 수요 증가, 다양한 NGS 제품의 가용성 등이 시장을 주도하고 있습니다.

이 보고서는 NGS 기술의 발전이 향후 몇 년 동안 차세대 시퀀싱(NGS) 시장의 성장을 가속하는 주요 이유 중 하나로 꼽았습니다. 또한, 유전자 시퀀싱의 비용 절감, 바이오인포매틱스 및 클라우드 기반 소프트웨어 프로그램의 신흥국 시장 개발은 시장의 큰 수요로 이어질 것으로 보입니다.

목차

제1장 주요 요약

  • 시장 개요

제2장 시장 구도

  • 시장 생태계

제3장 시장 규모

  • 시장의 정의
  • 시장별 부문 분석
  • 시장 규모(2022년)
  • 시장 전망(2022-2027년)

제4장 시장 규모 실적

  • 세계의 차세대 시퀸싱(NGS) 시장(2017-2021년)
  • 최종사용자별 부문 분석(2017-2021년)
  • 제품별 부문 분석(2017-2021년)
  • 지역별 부문 분석(2017-2021년)
  • 국가별 부문 분석(2017-2021년)

제5장 Five Forces 분석

  • Five Forces 요약
  • 바이어의 교섭력
  • 공급 기업의 교섭력
  • 신규 진출업체의 위협
  • 대체품의 위협
  • 경쟁 위협
  • 시장 현황

제6장 시장 세분화 : 최종사용자별

  • 시장 부문
  • 비교 : 최종사용자별
  • 학술 연구 : 시장 규모와 예측(2022-2027년)
  • 임상 연구 : 시장 규모와 예측(2022-2027년)
  • 제약회사 및 바이오테크놀러지 기업 : 시장 규모와 예측(2022-2027년)
  • 기타 : 시장 규모와 예측(2022-2027년)
  • 시장 기회 : 최종사용자별

제7장 시장 세분화 : 제품별

  • 시장 부문
  • 비교 : 제품별
  • 소모품 : 시장 규모와 예측(2022-2027년)
  • 장비 : 시장 규모와 예측(2022-2027년)
  • 시장 기회 : 제품별

제8장 고객 상황

  • 고객 상황 개요

제9장 지역별 상황

  • 지역별 세분화
  • 지역별 비교
  • 북미 : 시장 규모와 예측(2022-2027년)
  • 유럽 : 시장 규모와 예측(2022-2027년)
  • 아시아 : 시장 규모와 예측(2022-2027년)
  • 세계 기타 지역 : 시장 규모와 예측(2022-2027년)
  • 미국 : 시장 규모와 예측(2022-2027년)
  • 독일 : 시장 규모와 예측(2022-2027년)
  • 캐나다 : 시장 규모와 예측(2022-2027년)
  • 중국 : 시장 규모와 예측(2022-2027년)
  • 영국 : 시장 규모와 예측(2022-2027년)
  • 지역 상황별 시장 기회

제10장 성장 촉진요인, 과제 및 동향

  • 시장 성장 촉진요인
  • 시장이 해결해야 할 과제
  • 성장 촉진요인과 과제의 영향
  • 시장 동향

제11장 벤더 구도

  • 개요
  • 벤더 구도
  • 혼란 상황
  • 업계 리스크

제12장 벤더 분석

  • 대상 벤더
  • 벤더의 시장 포지셔닝
  • 10X Genomics Inc.
  • Azenta Inc.
  • BGI Genomics Co. Ltd.
  • Bio Rad Laboratories Inc.
  • Eurofins Scientific SE
  • F. Hoffmann La Roche Ltd.
  • Illumina Inc.
  • Konica Minolta Inc.
  • Laboratory Corp. of America Holdings
  • Merck KGaA
  • Perkin Elmer Inc.
  • QIAGEN NV
  • Standard BioTools Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

제13장 부록

LSH 23.06.28

The next generation sequencing market is forecasted to grow by USD 3409.76 mn during 2022-2027, accelerating at a CAGR of 12.45% during the forecast period. The report on the next generation sequencing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased utilization of NGS methods, growing demand for early diagnosis of genetic disorders, and availability of wide range of NGS products.

Technavio's next generation sequencing market is segmented as below:

By End-user

  • Academic research
  • Clinical research
  • Pharma & biotech companies
  • Others

By Product

  • Consumables
  • Equipment

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the advances in NGS techniques as one of the prime reasons driving the next generation sequencing market growth during the next few years. Also, reduced costs of gene sequencing and developments in bioinformatics and cloud-based software programs will lead to sizable demand in the market.

The report on the next generation sequencing market covers the following areas:

  • Next generation sequencing market sizing
  • Next generation sequencing market forecast
  • Next generation sequencing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading next generation sequencing market vendors that include 10X Genomics Inc., Azenta Inc., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc., Konica Minolta Inc., Laboratory Corp. of America Holdings, Merck KGaA, Nabsys Inc., OPKO Health Inc., Oxford Nanopore Technologies plc, Perkin Elmer Inc., PierianDx Inc., Psomagen Inc., QIAGEN NV, Standard BioTools Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc.. Also, the next generation sequencing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global next generation sequencing market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on global next generation sequencing market 2017 - 2021 ($ million)
  • 4.2 End-user Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
  • 4.3 Product Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

  • 6.1 Market segments
  • Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
  • 6.2 Comparison by End-user
  • Exhibit 32: Chart on Comparison by End-user
  • Exhibit 33: Data Table on Comparison by End-user
  • 6.3 Academic research - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Academic research - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Academic research - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Academic research - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Academic research - Year-over-year growth 2022-2027 (%)
  • 6.4 Clinical research - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Clinical research - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Clinical research - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Clinical research - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Clinical research - Year-over-year growth 2022-2027 (%)
  • 6.5 Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027
  • Exhibit 42: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 43: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 44: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
  • Exhibit 45: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
  • 6.6 Others - Market size and forecast 2022-2027
  • Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
  • Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
  • 6.7 Market opportunity by End-user
  • Exhibit 50: Market opportunity by End-user ($ million)
  • Exhibit 51: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Product

  • 7.1 Market segments
  • Exhibit 52: Chart on Product - Market share 2022-2027 (%)
  • Exhibit 53: Data Table on Product - Market share 2022-2027 (%)
  • 7.2 Comparison by Product
  • Exhibit 54: Chart on Comparison by Product
  • Exhibit 55: Data Table on Comparison by Product
  • 7.3 Consumables - Market size and forecast 2022-2027
  • Exhibit 56: Chart on Consumables - Market size and forecast 2022-2027 ($ million)
  • Exhibit 57: Data Table on Consumables - Market size and forecast 2022-2027 ($ million)
  • Exhibit 58: Chart on Consumables - Year-over-year growth 2022-2027 (%)
  • Exhibit 59: Data Table on Consumables - Year-over-year growth 2022-2027 (%)
  • 7.4 Equipment - Market size and forecast 2022-2027
  • Exhibit 60: Chart on Equipment - Market size and forecast 2022-2027 ($ million)
  • Exhibit 61: Data Table on Equipment - Market size and forecast 2022-2027 ($ million)
  • Exhibit 62: Chart on Equipment - Year-over-year growth 2022-2027 (%)
  • Exhibit 63: Data Table on Equipment - Year-over-year growth 2022-2027 (%)
  • 7.5 Market opportunity by Product
  • Exhibit 64: Market opportunity by Product ($ million)
  • Exhibit 65: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 69: Chart on Geographic comparison
  • Exhibit 70: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 Germany - Market size and forecast 2022-2027
  • Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.9 Canada - Market size and forecast 2022-2027
  • Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • 9.10 China - Market size and forecast 2022-2027
  • Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.11 UK - Market size and forecast 2022-2027
  • Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 107: Market opportunity By Geographical Landscape ($ million)
  • Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 109: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 111: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 112: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 113: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 114: Matrix on vendor position and classification
  • 12.3 10X Genomics Inc.
  • Exhibit 115: 10X Genomics Inc. - Overview
  • Exhibit 116: 10X Genomics Inc. - Product / Service
  • Exhibit 117: 10X Genomics Inc. - Key offerings
  • 12.4 Azenta Inc.
  • Exhibit 118: Azenta Inc. - Overview
  • Exhibit 119: Azenta Inc. - Business segments
  • Exhibit 120: Azenta Inc. - Key offerings
  • Exhibit 121: Azenta Inc. - Segment focus
  • 12.5 BGI Genomics Co. Ltd.
  • Exhibit 122: BGI Genomics Co. Ltd. - Overview
  • Exhibit 123: BGI Genomics Co. Ltd. - Product / Service
  • Exhibit 124: BGI Genomics Co. Ltd. - Key offerings
  • 12.6 Bio Rad Laboratories Inc.
  • Exhibit 125: Bio Rad Laboratories Inc. - Overview
  • Exhibit 126: Bio Rad Laboratories Inc. - Business segments
  • Exhibit 127: Bio Rad Laboratories Inc. - Key news
  • Exhibit 128: Bio Rad Laboratories Inc. - Key offerings
  • Exhibit 129: Bio Rad Laboratories Inc. - Segment focus
  • 12.7 Eurofins Scientific SE
  • Exhibit 130: Eurofins Scientific SE - Overview
  • Exhibit 131: Eurofins Scientific SE - Business segments
  • Exhibit 132: Eurofins Scientific SE - Key news
  • Exhibit 133: Eurofins Scientific SE - Key offerings
  • Exhibit 134: Eurofins Scientific SE - Segment focus
  • 12.8 F. Hoffmann La Roche Ltd.
  • Exhibit 135: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 136: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 137: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 138: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 139: F. Hoffmann La Roche Ltd. - Segment focus
  • 12.9 Illumina Inc.
  • Exhibit 140: Illumina Inc. - Overview
  • Exhibit 141: Illumina Inc. - Business segments
  • Exhibit 142: Illumina Inc. - Key news
  • Exhibit 143: Illumina Inc. - Key offerings
  • Exhibit 144: Illumina Inc. - Segment focus
  • 12.10 Konica Minolta Inc.
  • Exhibit 145: Konica Minolta Inc. - Overview
  • Exhibit 146: Konica Minolta Inc. - Business segments
  • Exhibit 147: Konica Minolta Inc. - Key news
  • Exhibit 148: Konica Minolta Inc. - Key offerings
  • Exhibit 149: Konica Minolta Inc. - Segment focus
  • 12.11 Laboratory Corp. of America Holdings
  • Exhibit 150: Laboratory Corp. of America Holdings - Overview
  • Exhibit 151: Laboratory Corp. of America Holdings - Business segments
  • Exhibit 152: Laboratory Corp. of America Holdings - Key news
  • Exhibit 153: Laboratory Corp. of America Holdings - Key offerings
  • Exhibit 154: Laboratory Corp. of America Holdings - Segment focus
  • 12.12 Merck KGaA
  • Exhibit 155: Merck KGaA - Overview
  • Exhibit 156: Merck KGaA - Business segments
  • Exhibit 157: Merck KGaA - Key news
  • Exhibit 158: Merck KGaA - Key offerings
  • Exhibit 159: Merck KGaA - Segment focus
  • 12.13 Perkin Elmer Inc.
  • Exhibit 160: Perkin Elmer Inc. - Overview
  • Exhibit 161: Perkin Elmer Inc. - Business segments
  • Exhibit 162: Perkin Elmer Inc. - Key news
  • Exhibit 163: Perkin Elmer Inc. - Key offerings
  • Exhibit 164: Perkin Elmer Inc. - Segment focus
  • 12.14 QIAGEN NV
  • Exhibit 165: QIAGEN NV - Overview
  • Exhibit 166: QIAGEN NV - Product / Service
  • Exhibit 167: QIAGEN NV - Key news
  • Exhibit 168: QIAGEN NV - Key offerings
  • 12.15 Standard BioTools Inc.
  • Exhibit 169: Standard BioTools Inc. - Overview
  • Exhibit 170: Standard BioTools Inc. - Product / Service
  • Exhibit 171: Standard BioTools Inc. - Key news
  • Exhibit 172: Standard BioTools Inc. - Key offerings
  • 12.16 Takara Bio Inc.
  • Exhibit 173: Takara Bio Inc. - Overview
  • Exhibit 174: Takara Bio Inc. - Business segments
  • Exhibit 175: Takara Bio Inc. - Key offerings
  • Exhibit 176: Takara Bio Inc. - Segment focus
  • 12.17 Thermo Fisher Scientific Inc.
  • Exhibit 177: Thermo Fisher Scientific Inc. - Overview
  • Exhibit 178: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 179: Thermo Fisher Scientific Inc. - Key news
  • Exhibit 180: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 181: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 182: Inclusions checklist
  • Exhibit 183: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 184: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 185: Research methodology
  • Exhibit 186: Validation techniques employed for market sizing
  • Exhibit 187: Information sources
  • 13.5 List of abbreviations
  • Exhibit 188: List of abbreviations
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제